New EMA guideline: Handling and shipping of IMPs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2018-05-24 15:45  – Posting: # 18814
Views: 883

Dear all,

today the EMA published the “Draft guideline on the responsibilities of the sponsor with regard to handling and shipping of investigational medicinal products for human use in accordance with Good Clinical Practice and Good Manufacturing Practice”. End of consultation is on 31 August 2018.

Have also a look at the applicable guidelines on Good Distribution Practice (GDP):

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,265 posts in 4,098 threads, 1,314 registered users;
online 15 (1 registered, 14 guests [including 12 identified bots]).

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5